Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients (Q33398899)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients (English)

1 reference

Europe PubMed Central

26 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

P Mancosu

6

0 references

object named as

F Alongi

1

0 references

Marta Scorsetti

object named as

M Scorsetti

18

0 references

Armando Santoro

1 reference

ORCID Public Data File 2021

author name string

M Bignardi

2

1 reference

Europe PubMed Central

26 July 2017

I Garassino

3

1 reference

Europe PubMed Central

26 July 2017

S Pentimalli

4

1 reference

Europe PubMed Central

26 July 2017

R Cavina

5

1 reference

Europe PubMed Central

26 July 2017

G Reggiori

7

1 reference

Europe PubMed Central

26 July 2017

A Poletti

8

1 reference

Europe PubMed Central

26 July 2017

D Ferrari

9

1 reference

Europe PubMed Central

26 July 2017

P Foa

10

1 reference

Europe PubMed Central

26 July 2017

A Bigoni

11

1 reference

Europe PubMed Central

26 July 2017

A Dragonetti

12

1 reference

Europe PubMed Central

26 July 2017

P Salvatori

13

1 reference

Europe PubMed Central

26 July 2017

O Spahiu

14

1 reference

Europe PubMed Central

26 July 2017

A Fogliata

15

1 reference

Europe PubMed Central

26 July 2017

L Cozzi

16

1 reference

Europe PubMed Central

26 July 2017

A Santoro

17

1 reference

Europe PubMed Central

26 July 2017

publication date

24 December 2011

1 reference

Europe PubMed Central

26 July 2017

Strahlentherapie und Onkologie

1 reference

Europe PubMed Central

26 July 2017

188

1 reference

Europe PubMed Central

26 July 2017

1

1 reference

Europe PubMed Central

26 July 2017

49-55

1 reference

Europe PubMed Central

26 July 2017

https://scigraph.springernature.com/pub.10.1007/s00066-011-0006-y

0 references

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Targeted therapy in head and neck cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Severe skin reaction secondary to concomitant radiotherapy plus cetuximab

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Volumetric modulated arc therapy for advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. E

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

HPV & head and neck cancer: a descriptive update

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0006-Y

21 January 2018

Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22194030

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RapidArc Planning and Delivery in Patients With Locally Advanced Head-and-Neck Cancer Undergoing Chemoradiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22194030

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose fractionation and volume effects in normal tissues and tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22194030

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-dimensional conformal vs. intensity-modulated radiotherapy in head-and-neck cancer patients: comparative analysis of dosimetric and technical parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/22194030

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Volumetric Intensity-Modulated Arc Therapy Vs. Conventional IMRT in Head-and-Neck Cancer: A Comparative Planning and Dosimetric Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22194030

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/22194030

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/22194030

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotactic Body Radiation Therapy (SBRT) for adrenal metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22194030

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22194030

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT

1 reference

https://pubmed.ncbi.nlm.nih.gov/22194030

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of the clinical evidence for intensity-modulated radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22194030

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00066-011-0006-Y

1 reference

Europe PubMed Central

26 July 2017

Dimensions Publication ID

0 references

release_ijkg4at455cdxmesux2dhgvf5y

1 reference

https://api.fatcat.wiki/v0/release/ijkg4at455cdxmesux2dhgvf5y

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33398899&oldid=1840608931"